Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration
Authors
Keywords
Chitosan coated nanoparticle, Diabetic retinopathy, Bevacizumab, Subconjuntival administration
Journal
CARBOHYDRATE POLYMERS
Volume -, Issue -, Pages 118217
Publisher
Elsevier BV
Online
2021-05-18
DOI
10.1016/j.carbpol.2021.118217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
- (2021) Hyeong Min Kim et al. Pharmaceutics
- Protein-Based Nanoparticles as Drug Delivery Systems
- (2020) Seyoung Hong et al. Pharmaceutics
- Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia
- (2018) Di Huang et al. BIOMATERIALS
- Human serum albumin nanoparticles for ocular delivery of bevacizumab
- (2018) Inés Luis de Redín et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation
- (2016) Jayamanti Pandit et al. Artificial Cells Nanomedicine and Biotechnology
- Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment
- (2015) Reyhaneh Varshochian et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future
- (2014) Tsong Qiang Kwong et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy
- (2014) Rafael Simó et al. DIABETES CARE
- Using the Past to Inform the Future: Anti-VEGF Therapy as a Road Map to Develop Novel Therapies for Diabetic Retinopathy
- (2013) P. M. Titchenell et al. DIABETES
- The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments
- (2013) Reyhaneh Varshochian et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Light-Activated, In Situ Forming Gel for Sustained Suprachoroidal Delivery of Bevacizumab
- (2013) Puneet Tyagi et al. MOLECULAR PHARMACEUTICS
- Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
- (2013) Andrew A. Chang et al. OPHTHALMOLOGY
- Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats
- (2012) Claudio Bucolo et al. BIOCHEMICAL PHARMACOLOGY
- Diabetic Retinopathy
- (2012) David A. Antonetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Release of Bevacizumab by Thermosensitive Biodegradable and Biocompatible Hydrogel
- (2011) Chau-Hui Wang et al. BIOMACROMOLECULES
- Comparison of Long-Acting Bevacizumab Formulations in the Treatment of Choroidal Neovascularization in a Rat Model
- (2011) Carolyn K. Pan et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Effect of an intravitreal injection of bevacizumab on the expression of VEGF and CD34 in the retina of diabetic rats
- (2010) Jin Ma et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Microscopic and spectroscopic evaluation of novel PLGA–chitosan Nanoplexes as an ocular delivery system
- (2010) Gaurav K. Jain et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- A review of clinical trials of anti-VEGF agents for diabetic retinopathy
- (2010) Benjamin P. Nicholson et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Diabetic retinopathy
- (2010) Ning Cheung et al. LANCET
- Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration
- (2009) ARCHIVES OF INTERNAL MEDICINE
- Subconjunctivally implantable hydrogels with degradable and thermoresponsive properties for sustained release of insulin to the retina
- (2009) Gauri P. Misra et al. BIOMATERIALS
- PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION
- (2009) MAJID ABRISHAMI et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The capsule drug device: Novel approach for drug delivery to the eye
- (2009) Sarah A. Molokhia et al. VISION RESEARCH
- The intracellular uptake ability of chitosan-coated Poly (D,L-lactideco-glycolide) nanoparticles
- (2008) Beom-Su Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
- (2008) R. Simó et al. DIABETOLOGIA
- LONG-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR THE MANAGEMENT OF CENTRAL RETINAL VEIN OCCLUSION
- (2008) NINEL Z. GREGORI et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started